These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Identification of hypoxic macrophages in glioblastoma: Unveiling therapeutic insights from tumour microenvironment analysis. Qin Z; Bian XW; Shi Y Clin Transl Med; 2024 Sep; 14(9):e70013. PubMed ID: 39297872 [TBL] [Abstract][Full Text] [Related]
45. PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response. Li J; Kaneda MM; Ma J; Li M; Shepard RM; Patel K; Koga T; Sarver A; Furnari F; Xu B; Dhawan S; Ning J; Zhu H; Wu A; You G; Jiang T; Venteicher AS; Rich JN; Glass CK; Varner JA; Chen CC Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846242 [TBL] [Abstract][Full Text] [Related]
46. A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma. Yin W; Ping YF; Li F; Lv SQ; Zhang XN; Li XG; Guo Y; Liu Q; Li TR; Yang LQ; Yang KD; Liu YQ; Luo CH; Luo T; Wang WY; Mao M; Luo M; He ZC; Cao MF; Chen C; Miao JY; Zeng H; Wang C; Zhou L; Yang Y; Yang X; Wang QH; Feng H; Shi Y; Bian XW J Pathol; 2022 Oct; 258(2):121-135. PubMed ID: 35723032 [TBL] [Abstract][Full Text] [Related]
47. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition. Rao R; Han R; Ogurek S; Xue C; Wu LM; Zhang L; Zhang L; Hu J; Phoenix TN; Waggoner SN; Lu QR Neuro Oncol; 2022 Apr; 24(4):584-597. PubMed ID: 34562087 [TBL] [Abstract][Full Text] [Related]
48. Specialized functions and sexual dimorphism explain the functional diversity of the myeloid populations during glioma progression. Ochocka N; Segit P; Wojnicki K; Cyranowski S; Swatler J; Jacek K; Grajkowska W; Kaminska B Cell Rep; 2023 Jan; 42(1):111971. PubMed ID: 36640350 [TBL] [Abstract][Full Text] [Related]
50. TAMs in Brain Metastasis: Molecular Signatures in Mouse and Man. Schulz M; Sevenich L Front Immunol; 2021; 12():716504. PubMed ID: 34539650 [TBL] [Abstract][Full Text] [Related]
51. The landscape of the mesenchymal signature in brain tumours. Behnan J; Finocchiaro G; Hanna G Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477 [TBL] [Abstract][Full Text] [Related]
52. Blood monocyte-derived CD169 Kim HJ; Park JH; Kim HC; Kim CW; Kang I; Lee HK Nat Commun; 2022 Oct; 13(1):6211. PubMed ID: 36266311 [TBL] [Abstract][Full Text] [Related]
53. Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features. Hide T; Shibahara I; Kumabe T Brain Tumor Pathol; 2019 Apr; 36(2):63-73. PubMed ID: 30968276 [TBL] [Abstract][Full Text] [Related]
55. Why Don't the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment. Mohapatra S; Cafiero J; Kashfi K; Mehta P; Banerjee P Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902456 [TBL] [Abstract][Full Text] [Related]
56. Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma. Landry AP; Balas M; Alli S; Spears J; Zador Z Sci Rep; 2020 Nov; 10(1):19542. PubMed ID: 33177572 [TBL] [Abstract][Full Text] [Related]
57. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma. Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018 [TBL] [Abstract][Full Text] [Related]
58. Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion. Cao MF; Chen L; Dang WQ; Zhang XC; Zhang X; Shi Y; Yao XH; Li Q; Zhu J; Lin Y; Liu S; Chen Q; Cui YH; Zhang X; Bian XW Cancer Lett; 2019 Feb; 442():445-452. PubMed ID: 30472185 [TBL] [Abstract][Full Text] [Related]
59. Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas. Sielska M; Przanowski P; Pasierbińska M; Wojnicki K; Poleszak K; Wojtas B; Grzeganek D; Ellert-Miklaszewska A; Ku MC; Kettenmann H; Kaminska B Br J Cancer; 2020 Aug; 123(3):438-448. PubMed ID: 32390004 [TBL] [Abstract][Full Text] [Related]
60. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells. Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]